Cite
MLA Citation
Paul Kim et al.. “1083. Phase 1b Results of Pharmacokinetics, Pharmacodynamics, and Safety for LBP-EC01, a CRISPR-Cas3 Enhanced Bacteriophage Cocktail Targeting Escherichia coli that Cause Urinary Tract Infections.” Open forum infectious diseases, vol. 8, n.d., p. S633. http://access.bl.uk/ark:/81055/vdc_100150543206.0x000020